 |
|
Hypopyon Uveitis in Patients With Acquired Immunodeficiency Syndrome Treated for Systemic Mycobacterium avium Complex Infection With Rifabutin
Bruce R. Saran, MD;
Albert M. Maguire, MD;
Charles Nichols, MD;
Ian Frank, MD;
Richard W. Hertle, MD;
Alexander J. Brucker, MD;
Stephen Goldman, MD;
Melissa Brown, MD;
Bonnie Van Uitert, MD
Arch Ophthalmol. 1994;112(9):1159-1165.
Abstract
| |
Objective
Iridocyclitis has been identified as a dosage-dependent side effect in patients with the acquired immunodeficiency syndrome (AIDS) who are treated for Mycobacterium avium complex (MAC) infection with systemic rifabutin. We reviewed cases of acute hypopyon uveitis occurring in patients with AIDS to establish whether there was an association.
Design
Retrospective case series.
Setting
Outpatient clinic and inpatient hospital-based ophthalmology referral practice and infectious disease specialty service.
Patients
Seven patients with AIDS, aged 10 to 40 years, presenting with acute unilateral hypopyon mimicking infectious endophthalmitis.
Main Outcome Measures
Findings from complete ophthalmological evaluation and ancillary laboratory testing.
Results
At the time of presentation, all seven patients were receiving treatment for MAC infection with rifabutin (dosage range, 300 to 600 mg/d) and clarithromycin. Results of microbiological investigations in five patients were negative. Iridocyclitis became bilateral in all seven patients, and hypopyon developed in the contralateral eye in five of seven patients. Hypopyon resolved rapidly with intensive topical corticosteroid therapy. Residual inflammation responded to topical corticosteroids with or without reduction of the rifabutin dosage.
Conclusions
Concomitant use of rifabutin, clarithromycin, and fluconazole may precipitate hypopyon uveitis in patients with AIDS being treated for MAC infection.
Author Affiliations
From the Department of Ophthalmology, Scheie Eye Institute (Drs Saran, Maguire, Nichols, Hertle, and Brucker), and the Department of Infectious Diseases (Dr Frank), University of Pennsylvania, the Pennsylvania Hospital (Dr Goldman), and Wills Eye Hospital, Thomas Jefferson University (Dr Brown), Philadelphia; and the Department of Infectious Diseases, Presbyterian Medical Center of Philadelphia (Dr Uitert). The authors do not have any commercial or proprietary interest in the drugs discussed in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Uveitis in a patient receiving rifabutin for Crohn's disease
Awotesu et al.
JRSM 2004;97:440-441.
FULL TEXT
Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemia
Golchin and McClellan
Br J Ophthalmol 2003;87:798-799.
FULL TEXT
Rifabutin-induced cystoid macular oedema
Vaudaux and Guex-Crosier
J Antimicrob Chemother 2002;49:421-422.
ABSTRACT
| FULL TEXT
Uveitis associated with OKT3 therapy for renal transplant rejection
GARIANO and WEITZMAN
Br J Ophthalmol 2001;85:496e-496.
FULL TEXT
Iritis and Hypotony After Treatment With Intravenous Cidofovir for Cytomegalovirus Retinitis
Davis et al.
Arch Ophthalmol 1997;115:733-737.
ABSTRACT
Cidofovir
Jabs
Arch Ophthalmol 1997;115:785-786.
ABSTRACT
Ocular Manifestations of AIDS
Whitcup
JAMA 1996;275:142-144.
ABSTRACT
Rifabutin Use in Inflammatory Bowel Disease
To et al.
Arch Ophthalmol 1995;113:1354-1354.
ABSTRACT
Ophthalmology
Levin
JAMA 1995;273:1703-1705.
ABSTRACT
Rifabutin-Associated Uveitis During Prophylaxis for Mycobacterium avium Complex Infection
Rifai et al.
Arch Ophthalmol 1995;113:707-707.
ABSTRACT
Acute Uveitis in Patients With Acquired Immunodeficiency Syndrome Receiving Prophylactic Rifabutin
Karbassi and Nikou
Arch Ophthalmol 1995;113:699-701.
ABSTRACT
|
